Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis: Effects of low-dose corticosteroids
Article first published online: 30 APR 2012
Copyright © 1993 American College of Rheumatology
Arthritis & Rheumatism
Volume 36, Issue 2, pages 222–228, February 1993
How to Cite
Garton, M. J. and Reid, D. M. (1993), Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis: Effects of low-dose corticosteroids. Arthritis & Rheumatism, 36: 222–228. doi: 10.1002/art.1780360213
- Issue published online: 30 APR 2012
- Article first published online: 30 APR 2012
- Manuscript Accepted: 1 OCT 1992
- Arthritis and Rheumatism Council and the Wolfson Foundation
Objective. To assess bone mineral density (BMD) in men with steroid-treated rheumatoid arthritis (RA).
Methods. Dual-energy x-ray absorptiometry (DXA) was used to measure BMD in 40 men with RA, 20 of whom were receiving low-dose corticosteroids (≤10 mg prednisolone daily), and in 20 healthy, age-matched male controls.
Results. BMD was significantly reduced at the femoral neck and greater trochanter in both groups of RA patients, and at the spine from the anteroposterior dimension in the steroid-treated group.
Conclusion. Low-dose steroid therapy may induce excess axial osteopenia in men with RA.